NUVISAN-GROUP
On August 31st the NUVISAN GROUP, one of Europe´s leading CRO´s focused on early stage drug development for the life science industry, signed an agreement with NESTLÉ SKIN HEALTH/ GALDERMA to take over parts of the R&D capacities in Sophia-Antipolis, France.
The GALDERMA R&D site in Sophia-Antipolis which opened in 2006 is the world’s largest research and development center focused on medical and cosmetic solutions for the skin. The new capabilities will strengthen NUVISAN’S core service lines in Bioanalysis, Clinical Trial Supplies and Pharmaceutical Analytics as well as enhancing the portfolio by adding GMP-API synthesis and formulation capability for prescription drugs and cosmetics. NUVISAN intends to start its operations in Sophia Antipolis in October 2018.
NUVISAN thus underscores its claim to becoming Europe’s leading one-stop pharma services provider in the field of early stage drug development for the pharmaceutical industry with its third acquisition since 2011. The integration of parts of the former GALDERMA R&D will add 80 employees to NUVISAN's existing 325 employees to give 400+ employees in the NUVISAN GROUP.
"With these new R&D capabilities and capacities, we not only integrate a high-performance team, but also obtain access to a great deal of specialty know-how which we can bundle directly into the NUVISAN GROUP, enabling us to significantly increase and enhance benefits to our customers " says CEO of NUVISAN, Dr. Dietrich Bruchmann.
NUVISAN is now able to significantly accelerate the drug development process from discovery to clinical trials for clients.
With these new capacities, NUVISAN expertise will be extended to the fields of chemistry, liquid and semi-solid formulation development whilst creating an operational hub in close proximity to Southern European customers.
About NUVISAN
The owner-managed NUVISAN GROUP generates sales of approx. € 40 million with currently over 300 highly qualified employees. It originated from LAB AAI Pharma 40 years ago and has been operating under the name NUVISAN GmbH with its headquarters in Neu-Ulm since 2010. With the addition of the new R&D capacities, the headcount will increase by more than 20% and brings NUVISAN to app. 400+ employees.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180905005854/en/
Contact:
NUVISAN Dr. rer. medic. David Surjo Executive Vice President Pharmaceutical Services Phone: +49 731 9840 235 / +49 162 4061 836 Email: david.surjo@nuvisan.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation7.5.2025 18:55:00 CEST | Press release
Pharmaceutical manufacturer layers ServiceNow over its existing SAP ECC 6 ERP platform, enables intelligent workflow and automation for immediate business impact and avoids low ROI spend on expensive, risky vendor-mandated migration to SAP S/4HANA Knowledge 2025 —Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today at ServiceNow’s annual customer and partner event, Knowledge 2025, announced that Apsen Farmacêutica, a Brazilian pharmaceutical manufacturer, has partnered with Rimini Street and ServiceNow to implement a next-generation vision of enterprise-wide workflow automation. This new vision will enable autonomy across the company to help respond faster to market changes, reduce information silos and improve operational efficiency. This press release features multimedia. View the full release here: https://www.busine
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials7.5.2025 18:07:00 CEST | Press release
Study conducted by VirTus Respiratory Research demonstrated that vapendavir has potent antiviral activity and improves symptoms in participants with COPD infected with rhinovirus VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa BioSciences with compelling evidence to advance their lead drug candidate, vapendavir, into large scale, late-stage clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507489716/en/ Professor Sebastian Johnston https://www.prnewswire.com/news-releases/altesa-biosciences-details-positive-topline-vapendavir-results-from-phase-2-placebo-controlled-rhinovirus-challenge-study-in-copd-patients-302448650.html Rhinovirus infection is the cause of at least half of the acute respiratory deteriorat
FlightSafety International Announces Major Expansion at Farnborough Airport7.5.2025 17:56:00 CEST | Press release
FlightSafety International (FSI), a global leader in aviation training, is pleased to announce the expansion of its facilities at Farnborough Airport, the home of British aviation and Europe’s leading airport for premium air travel connectivity, highlighting its commitment to enhancing aviation safety and training excellence in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506583636/en/ Rendering: arriving at FlightSafety International The new FSI centre is expected to open in the second quarter of 2027. Lease terms have been finalised and the planning application was submitted in January. Construction is scheduled to start in late 2025 and finish by early 2027. FSI has operated a training centre at Farnborough Airport since 2004. The new facilities will boost training capacity by 40-50%, enabling more aviation professionals access to FSI's world-class training programmes. The current facility is 4,680 square met
Verimatrix Positioned as a Leader and Ace Performer in the 2025 SPARK MatrixTM for In-App Protection by QKS Group7.5.2025 17:45:00 CEST | Press release
The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading In-App Protection vendors.Verimatrix is recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™.Verimatrix has also been named an Ace Performer – a recognition given to vendors that demonstrate revenue growth potential, partnership strategy, and customer acquisition – all evaluated over the last one-year period or since the previous SPARK Matrix™ assessment. Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507970501/en/ Verimatrix positioned as a Leader in the 2025 SPARK Matrix™ for In-App Protection by QKS Group. Verimatrix has been recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™. The compan
Amazon to Invest More Than $4 Billion to Launch Infrastructure Region in Chile7.5.2025 15:00:00 CEST | Press release
New AWS South America (Chile) Region will enable customers to run workloads and securely store their content in Chile while serving end users with even lower latencyActive customers in Chile include AgroSuper, Andres Bello University, Banco de Chile, Banco Itaú, BancoEstado, BCI Mach, Cencosud, Coca-Cola Andina, Coopeuch, Copec, Data Observatory, Femsa Salud, LATAM Airlines, Salcobrand, Transbank, and many others innovating on AWS Amazon (NASDAQ: AMZN) today announced it plans to launch an Amazon Web Services (AWS) infrastructure Region in Chile by the end of 2026. The new AWS South America (Chile) Region will give developers, startups, entrepreneurs, and enterprises, as well as financial services, retail, education, government, and nonprofit organizations, greater choice for running their applications and serving end users from data centers located in Chile. As part of its long-term commitment, Amazon is planning to invest more than $4 billion in Chile to support the construction, con
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom